Akums Drugs and Pharmaceuticals informs about updates

26 Nov 2024 Evaluate
Akums Drugs and Pharmaceuticals has informed that Maxcure Nutravedics (Maxcure), a wholly owned subsidiary of Akums Drugs and Pharmaceuticals (Akums) has entered into a Collaboration Agreement with Jagdale Industries (Jagdale). This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in carton packing for the Ready-to-Drink (RTD) market, targeting an expansive array of health and wellness products.

The above information is a part of company’s filings submitted to BSE.


Akums Drugs & Pharma Share Price

474.70 14.85 (3.23%)
28-Mar-2025 09:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...